Did you mean velneperit of s 2019 of ベルネペリット?
Displaying drugs 4951 - 4975 of 10517 in total
STX-100
STX-100 is under investigation in clinical trial NCT01371305 (STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)).
Investigational
STX-107
Investigational
SIG-007
SIG-007 is a gene therapy that consists of cells that are genetically modified with a non-viral vector to express human alpha-galactosidase A. Developed by Sigilon Therapeutics, t is being investigated for the treatment of Fabry Disease.
Investigational
Matched Description: … Developed by Sigilon Therapeutics, t is being investigated for the treatment of Fabry Disease. ... SIG-007 is a gene therapy that consists of cells that are genetically modified with a non-viral vector …
STP-707
STP-707 is a small interfering RNA (siRNA) targeting TGF-Beta1 and COX-2 mRNA.
Investigational
SIG-207
SIG-207 is a Cultured human retinal pigment epithelial cells (ARPE-19) genetically modified with a non-viral vector to express Human alpha-galactosidase A (alpha-Gal A), encapsulated within two-layer modified alginate spheres
Investigational
(R)-3-hydroxydecanoyl-CoA
Experimental
Sri-9439
Experimental
Suramin
A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties. Suramin...
Investigational
Matched Description: … A polyanionic compound with an unknown mechanism of action. ... It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with …
SOBI-003
SOBI-003 is a chemically modified variant of a recombinant human sulfamidase. It is under investigation in clinical trial NCT03811028 (A Study to Assess the Safety, Tolerability, and Efficacy of Long-term SOBI003 Treatment in Pediatric MPS IIIA Patients).
Investigational
Matched Description: … SOBI-003 is a chemically modified variant of a recombinant human sulfamidase. ... investigation in clinical trial NCT03811028 (A Study to Assess the Safety, Tolerability, and Efficacy of …
SRP-6004
A recombinant AAVrh74 gene therapy expressing the dysferlin transgene under control of a muscle-specific promoter (rAAVrh74.MHCK7.DYSF.DV).
Investigational
Matched Description: … A recombinant AAVrh74 gene therapy expressing the dysferlin transgene under control of a muscle-specific …
SXR-1096
Investigational
SLC-0111
Investigational
Dextromethadone
Dextromethadone is under investigation in clinical trial NCT00588640 (Study of D-Methadone in Patients With Chronic Pain).
Investigational
Matched Description: … Dextromethadone is under investigation in clinical trial NCT00588640 (Study of D-Methadone in Patients …
(4S,5S)-1,2-dithiane-4,5-diol
Experimental
Fenproporex
Fenproporex is an orally active stimulant drug, which was developed in the 1960s. It is used as an appetite suppressant and a treatment for obesity. It is listed as an illicit substance in many countries due to addiction issues and listed as a prohibited substance by the World Anti-Doping Agency....
Experimental
Illicit
Withdrawn
Matched Description: … In 2006 and 2009, the FDA issued warnings that it had been detected in diet pills sold online, and imported ... efficacy and safety data, and is listed as a drug in Schedule IV of the Controlled Substances Act. ... fenproporex (N-2-cyanoethylamphetamine) falls within the phenylethamine and amphetamine chemical class of …
4-(N,N-Dimethylamino)cinnamoyl-CoA
Experimental
Sri-9662
Experimental
SLx-4090
SLx-4090 is a microsomal triglyceride transfer protein (MTTP) inhibitor potentially for the treatment of type 2 diabetes.
Investigational
Matched Description: … SLx-4090 is a microsomal triglyceride transfer protein (MTTP) inhibitor potentially for the treatment of …
SurVaxM
Investigational
PAT-SM6
Investigational
Sorghum
Investigational
SPK-1001
Investigational
SC-74020
Experimental
Displaying drugs 4951 - 4975 of 10517 in total